Rizatriptan for Treatment of Acute Migraine in Patients Taking Topiramate for Migraine Prophylaxis

  1. Jeffrey L. Seeburger PhD,
  2. Roger K. Cady MD,
  3. Paul Winner DO,
  4. Anne MacGregor MD,
  5. Dominique Valade MD,
  6. Yang Ge PhD,
  7. Ying Zhang PhD,
  8. Carolyn M. Hustad PhD,
  9. Nancy Strickler BS,
  10. Eleanor Schaefer BS,
  11. Kathryn M. Connor MD,
  12. Tony W. Ho MD*

Article first published online: 11 NOV 2011

DOI: 10.1111/j.1526-4610.2011.02027.x

Issue

Headache: The Journal of Head and Face Pain

Headache: The Journal of Head and Face Pain

Volume 52, Issue 1, pages 57–67, January 2012

Additional Information

How to Cite

Seeburger, J. L., Cady, R. K., Winner, P., MacGregor, A., Valade, D., Ge, Y., Zhang, Y., Hustad, C. M., Strickler, N., Schaefer, E., Connor, K. M. and Ho, T. W. (2012), Rizatriptan for Treatment of Acute Migraine in Patients Taking Topiramate for Migraine Prophylaxis. Headache: The Journal of Head and Face Pain, 52: 57–67. doi: 10.1111/j.1526-4610.2011.02027.x

Author Information

  1. From Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA (J.L. Seeburger, Y. Ge, Y. Zhang, C.M. Hustad, N. Strickler, E. Schaefer, K.M. Connor, and T.W. Ho); Banyan Group Inc., Springfield, MO, USA (R.K. Cady); Palm Beach Headache Center, West Palm Beach, FL, USA (P. Winner); Barts and the London School of Medicine and Dentistry, London, England, UK (A. MacGregor); Centre d'Urgences Céphalées, Hôpital Lariboisière, Paris, France (D. Valade)

*T.W. Ho, Merck Sharp & Dohme Corp., 351 Sumneytown Pike, UG4C-06, North Wales, PA 19454, USA, email: tony.ho@merck.com

  1. Finance Support: This study was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

  2. Conflict of Interest: Drs. Cady, Winner, MacGregor, and Valade have received research grants and honoraria from Merck. Drs. Seeburger, Hustad, Ho, Ge, Zhang, and Connor and Ms. Strickler are employed by Merck and may own stock in the company. Ms. Schaefer was an employee of Merck at the time of the study.

Publication History

  1. Issue published online: 23 JAN 2012
  2. Article first published online: 11 NOV 2011
  3. Accepted for publication July 31, 2011.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (175K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Get PDF (175K)